Articles
Pharma goes mobile: Making the most of the app opportunity
As smartphones and tablets take over, pharma needs a strategic understanding of how mobile solutions improve customer outreach and drive competitive advantage. Andrew Tolve reports. Andrew TolveThe popularity of smartphones like the iPhone has created an...
Articles
Can personalised medicine save the pharma sector?
Personalised medicine is making a comeback – but will it stick this time? It was supposed to be the great saviour of the pharma industry – personalised medicine, the salve that would heal the sector from a drug drought,...
Articles
Utilising a CTMS to Create a Development Edge
As clinical trials become more globalised and complex, there is an increased need for investigators in all regions of the world, as well as for treatment-naïve patients. The industry faces demanding regulatory needs, as well as the complexities of...
Articles
Scientist gets his mind around Alzheimer’s
It’s not known what causes the disease or how to cure it. And the stakes have never been higher. But one European neuroscientist is leading the charge to uncover new treatments for this neurodegenerative disease. The...
Articles
Rodent models meeting need for reduced drug attrition rates
What are the strategies for reducing drug attrition rates in the clinic through the application of transgenic rodent models?‘Fail early, fail often’. It’s a paradigm that has long attached itself to the drug discovery focus on making improvements to...
Articles
Maximising Drug Discovery Research
Interview with: Teodor Aastrup, Chief Executive Officer, Attana AB "Drug discovery scientists should focus on the biological relevance of their candidate molecules as soon as possible in their research, to ensure a high probability of success...
Articles
State of the industry and the future of the sales force
eyeforpharma asked some of our key speakers for their insights on the “state of the industry and the future of the sales force”. Here’s what they had to say...How do you see the industry changing within the next five...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read